$GMHS

Gamehaus Holdings Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Requirement

Gamehaus Holdings Inc. (Nasdaq: GMHS) said Nasdaq notified it that its Class A ordinary shares’ closing bid fell below $1.00 for 30 straight business days, triggering Nasdaq Rule 5550(a)(2). The company has until Jan. 6, 2027 to regain compliance by closing at least $1.00 for 10 days, with possible extension.

Original reporting
Published Jul 13, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 11:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$GMHS
Neutral
medium confidence
Mentioned
$GMHS
Relevance
6/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$GMHSNeutralMed
01

Why it matters

The company has 180 calendar days to cure by achieving at least $1.00 closing bid for 10 consecutive business days. If not cured by January 6, 2027, it may seek an additional 180-day period by meeting other continued listing requirements and providing notice of intent to cure.

02

Market read

Traders should treat the $1.00 bid threshold as a near-term catalyst for volatility and risk pricing through the compliance window.

03

What to watch

The article does not state current bid/price levels or liquidity; actual trading behavior around $1.00 will depend on market demand and whether the company can sustain the required 10 consecutive business days above $1.00.

Relevance 6/10Novelty 6/10Timing: today’s Nasdaq notice starts a compliance timeline ending January 6, 2027.

Background

Nasdaq Listing Rule 5550(a)(2) requires a minimum $1.00 closing bid price; failure for 30 consecutive business days triggers a compliance notice.

Company-level read

Ticker impact

$GMHSNeutralMedium confidence
Context

Gamehaus received a Nasdaq notice that its closing bid fell below $1.00 for 30 straight business days, triggering a compliance clock.

Expected impact

Choppy trading risk, with traders watching for any sustained move back above $1.00 to avoid delisting escalation.

Evidence & confidence

The notice has no immediate trading effect, but it establishes a 180-day cure period to regain compliance, making the $1.00 level a key technical and risk-management reference.

Market effects

Highlights ongoing Nasdaq bid-price compliance pressure for micro/small-cap issuers, which can spill into sentiment for similar low-priced names.

Limited, as the event is company-specific on Nasdaq.

Low, since it is a US listing compliance matter with no stated international operational impact.

Counterpoint

Because the notice has no immediate effect and the company has a defined cure path, the market may over-discount the risk until the cure period nears.

Key entities

  • Gamehaus Holdings Inc.

    Nasdaq-listed mobile game publisher that received the minimum bid price compliance notice.

  • Nasdaq Stock Market LLC

    Exchange that issued the notification under Listing Rule 5550(a)(2) and Rule 5810(c)(3)(A).

Related articles

$GMHSMed

Gamehaus Holdings Inc. (GMHS): Financial results for Q4 2026

Gamehaus Holdings Inc. (GMHS) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2026 SHANGHAI, September 8, 2026 /PRNewswire/ — Gamehaus Holdings Inc. (“Gamehaus” or the “Company”) (Nasdaq: GMHS), a technology-driven mobile game pub

$CVSHigh

CVS Health to Split into Two Companies by 2028 — What Investors Need to Know

CVS Health (CVS) plans to split into two publicly traded companies by early 2028. One will retain the CVS Health name, including Aetna and Caremark, while the other will be CVS Pharmacy, with retail pharmacies and clinics. The move aims to address challenges in each business. CVS shares initially rose but later fell 1.8% in after-hours trading. The company is expected to report Q3 earnings with EPS of $1.65 and revenue of $104.69 billion.

$CVSMed

CVS Health Reportedly Plans to Split into Two Independent Entities as Business Restructuring Rumors Materialize

CVS Health (CVS) plans to split into two independent companies, separating its retail pharmacy business from its insurance and pharmacy benefit management operations. The retail pharmacy business, with 9,000 pharmacies, may become a separate public company. CVS Health shares rose 1.2% in after-hours trading following the report. The company's revenue reached $402.1 billion in 2025, up 7.8% year over year.